Ceribell (CBLL) Other financing activities (2024 - 2025)
Ceribell posted quarterly Other financing activities of $63000.0 for Q3 2025, down 76.49% on a QoQ basis from $268000.0 in Q2 2025.
Ceribell (CBLL) has 2 years of Other financing activities data on file, last reported at $63000.0 in Q3 2025.
- For the quarter ending Q3 2025, Other financing activities changed N/A year-over-year to $63000.0; the trailing twelve-month figure through Mar 2026 stood at $331000.0 (up 203.67% YoY), and the FY2025 full-year result was $150000.0, down 50.66% from the prior year.
- Other financing activities for Q3 2025 stood at $63000.0, down from $268000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $345000.0 in Q1 2024 and bottomed at -$41000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ceribell | 666.26 Mn | 525.07 Mn | 23.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 63,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | 268,000.00 |
| Jun 30, 2025 | 268,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Mar 31, 2024 | 345,000.00 |
| Mar 31, 2024 | 345,000.00 |